Conteltinib (CT-707) 是一种多激酶抑制剂,可靶向作用于 FAK,ALK 和 Pyk2。Conteltinib (CT-707) 对 FAK 具有显着的抑制作用,IC50 为 1.6 nM。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Conteltinib (CT-707) is a multi-kinase inhibitor targeting FAK, ALK, and Pyk2. Conteltinib (CT-707) exerts significant inhibitory effect on FAK with an IC50 of 1.6 nM[1]. IC50: 1.6 nM (FAK)[1]
[1]. Wang DD, et al. CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation. Mol Cancer Ther. 2016 Dec;15(12):2916-2925.
没有评价数据